Cantitate/Preț
Produs
Total produse
Vezi coșul
Virus Entry Inhibitors: Stopping the Enemy at the Gate de Shibo Jiang

Virus Entry Inhibitors: Stopping the Enemy at the Gate: Advances in Experimental Medicine and Biology, cartea 1366

Editat de Shibo Jiang, Lu Lu
en Limba Engleză Hardback – 13 apr 2022
This book focuses on the important discoveries of the small molecule-, peptide-, and protein-based virus entry inhibitors and discusses advance of the development of different type of virus entry inhibitors as a novel class of antiviral drugs for treatment and prevention of viral infection. It includes entry inhibitors of HIV,HeV, NiV, RSV, EBOV, HCoV, HBV, HCV, HDV, HPV, flavivirus and influenza virus, so on. This book aims at providing an updated knowledge on virus entry inhibitors.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 83559 lei  38-44 zile
  Springer Nature Singapore – 15 apr 2023 83559 lei  38-44 zile
Hardback (1) 85232 lei  38-44 zile
  Springer Nature Singapore – 13 apr 2022 85232 lei  38-44 zile

Din seria Advances in Experimental Medicine and Biology

Preț: 85232 lei

Preț vechi: 112146 lei
-24% Nou

Puncte Express: 1278
Preț estimativ în valută:
16312€ • 17206$ • 13632£

Carte tipărită la comandă

Livrare economică 28 decembrie 24 - 03 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9789811687013
ISBN-10: 9811687013
Pagini: 239
Ilustrații: X, 239 p. 1 illus.
Dimensiuni: 178 x 254 mm
Greutate: 0.71 kg
Ediția:1st ed. 2022
Editura: Springer Nature Singapore
Colecția Springer
Seria Advances in Experimental Medicine and Biology

Locul publicării:Singapore, Singapore

Cuprins

Peptide virus entry inhibitors: past, present and future.- Small-molecule virus entry inhibitors.- Human endogenous virus entry inhibitors.- Lipopeptide HIV entry inhibitors.- Peptide HIV entry inhibitors targeting gp41 NHR.- Small-molecule HIV entry inhibitors targeting gp41 MPER.- Small-molecule HIV entry inhibitors targeting CD4-binding site in gp120.- Small-molecule HIV entry inhibitors targeting gp120.- SARS-CoV, MERS-CoV, and pan-coronavirus entry inhibitors.- Hendra virus (HeV) and Nipah virus (NiV) entry inhibitors.- Ebola virus entry inhibitors.- Cyclo-peptide-based Ebola virus entry inhibitors.- Influenza virus entry inhibitors.- Parainfluenza virus entry inhibitors.- Zika virus entry inhibitors.- HBV entry inhibitors.- HBV and HDV entry inhibitors.- HCV entry inhibitors.- Protein-based HPV entry inhibitors.

Notă biografică

Dr. Shibo Jiang is a professor of School of Basic Medical Sciences, Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, China. He has served as an Editorial Consultant for The Lancet, Editorial Board Member for Emerging Microbes and Infection, Antiviral Research, Viruses, Retrovirology, BiochimBiophys Acta, Biomedical Journal, and Microbes and Infection. Dr. Jiang’s research interest is to develop antiviral therapeutics and vaccines against HIV, RSV, HPV, SARS-CoV, MERS-CoV, SARS-CoV-2, EBOV, ZIKV, NiV, LASV and influenza viruses. He has published 523 peer-reviewed papers in international journals, including Cell, Nature, Science, Lancet, etc. with more than 33,500 citations and h-index of 93 (Google Scholar).

Dr. Lu Lu is a professor of School of Basic Medical Sciences, Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, China. He serves as the committee member of Zoonoses Etiology Branch of the Chinese Society for Microbiology (CSM) and Associate director of Youth Committee of Medical Microbiology and Immunology branch of CSM. Dr. Lu’s research focuses on development of novel antiviral drugs and vaccines. He has published more than 118 articles in peer-reviewed international journals in this field, including Cell, Science, etc.

Textul de pe ultima copertă

This book focuses on the important discoveries of the small molecule-, peptide-, and protein-based virus entry inhibitors and discusses advance of the development of different type of virus entry inhibitors as a novel class of antiviral drugs for treatment and prevention of viral infection. It includes entry inhibitors of HIV,HeV, NiV, RSV, EBOV, HCoV, HBV, HCV, HDV, HPV, flavivirus and influenza virus, so on. This book aims at providing an updated knowledge on virus entry inhibitors.

Caracteristici

Introducing the cutting-edge developments of the small molecule-, peptide-, and protein-based virus entry inhibitors Covering the virus entry inhibitors to HIV, HeV, RSV, EBOV, HCoV, HBV, HCV, HDV, HPV, flavivirus and influenza virus etc Serving as a valuable reference tool to students and researchers in virology and scientists in pharmaceutical companies